Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Change in Cash: 2013-2024

Historic Change in Cash for Wave Life Sciences (WVE) over the last 12 years, with Dec 2024 value amounting to $101.8 million.

  • Wave Life Sciences' Change in Cash fell 107.80% to -$12.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$114.7 million, marking a year-over-year decrease of 167.04%. This contributed to the annual value of $101.8 million for FY2024, which is 9.03% down from last year.
  • Per Wave Life Sciences' latest filing, its Change in Cash stood at $101.8 million for FY2024, which was down 9.03% from $111.9 million recorded in FY2023.
  • Wave Life Sciences' Change in Cash's 5-year high stood at $111.9 million during FY2023, with a 5-year trough of -$62.1 million in FY2022.
  • Moreover, its 3-year median value for Change in Cash was $101.8 million (2024), whereas its average is $50.5 million.
  • Its Change in Cash has fluctuated over the past 5 years, first plummeted by 190.88% in 2021, then soared by 280.30% in 2023.
  • Wave Life Sciences' Change in Cash (Yearly) stood at $37.3 million in 2020, then slumped by 190.88% to -$33.9 million in 2021, then plummeted by 82.88% to -$62.1 million in 2022, then surged by 280.30% to $111.9 million in 2023, then declined by 9.03% to $101.8 million in 2024.